Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 21.2241.65-15.6018.7817.23

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 21.22 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202521.22
Mar202441.65
Mar2023-15.60
Mar202218.78
Mar202117.23

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 21.22
-49.05
Mar2024 41.65
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹94,905.1 Cr -5% 2.3% -5.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,469.0 Cr -2.8% -1% 6.7% Stock Analytics
DIVIS LABORATORIES ₹173,305.0 Cr -3.3% 0.4% -2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,014.0 Cr -3.1% 2.9% 36.9% Stock Analytics
CIPLA ₹111,388.0 Cr -2.7% 5.3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,381.0 Cr -4.1% -3.7% 3.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5%

2.3%

-5.4%

SENSEX

-2.4%

-3.7%

-9.2%


You may also like the below Video Courses